Login / Signup

An African-specific haplotype in MRGPRX4 is associated with menthol cigarette smoking.

Julia KozlitinaDavide RissoKatherine LansuReid Hans Johnson OlsenEduardo SainzDonata LuiselliArnab BarikCarlos Frigerio-DominguesLuca PaganiStephen WoodingThomas KirchnerRaymond S NiauraBryan RothDennis Drayna
Published in: PLoS genetics (2019)
In the U.S., more than 80% of African-American smokers use mentholated cigarettes, compared to less than 30% of Caucasian smokers. The reasons for these differences are not well understood. To determine if genetic variation contributes to mentholated cigarette smoking, we performed an exome-wide association analysis in a multiethnic population-based sample from Dallas, TX (N = 561). Findings were replicated in an independent cohort of African Americans from Washington, DC (N = 741). We identified a haplotype of MRGPRX4 (composed of rs7102322[G], encoding N245S, and rs61733596[G], T43T), that was associated with a 5-to-8 fold increase in the odds of menthol cigarette smoking. The variants are present solely in persons of African ancestry. Functional studies indicated that the variant G protein-coupled receptor encoded by MRGPRX4 displays reduced agonism in both arrestin-based and G protein-based assays, and alteration of agonism by menthol. These data indicate that genetic variation in MRGPRX4 contributes to inter-individual and inter-ethnic differences in the preference for mentholated cigarettes, and that the existence of genetic factors predisposing vulnerable populations to mentholated cigarette smoking can inform tobacco control and public health policies.
Keyphrases
  • african american
  • smoking cessation
  • public health
  • copy number
  • replacement therapy
  • high throughput
  • big data
  • machine learning
  • immune response
  • dna methylation
  • deep learning
  • single cell